Shares of Surgical Tool and Medical Instrument Stocks Are Trading Higher in Sympathy With Intuitive Surgical, Which Gained on Strong Q3 Earnings.
Tyra Raised to Buy by BofA Ahead of TYRA-300 Data Readout
'FDA Won't Take Action Against GLP-1 Compounders As It Rethinks Tirzepatide Shortage' - Endpoints News
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer Treatment
AbbVie Analyst Ratings
Johnson & Johnson Unusual Options Activity
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Shares of Health Insurance Stocks Are Trading Lower Following Recent Weak Earnings and Guidance From Multiple Companies in the Sector. CVS Fell on Friday Amid a CEO Change and Weak Guidance.
Behind the Scenes of Eli Lilly's Latest Options Trends
UnitedHealth Group Analyst Ratings
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
"Trump Trade" is restarting, what are the differences?
The new change of the "Trump trade" is that US technology stocks are more resilient, energy stocks are weaker, US bond yields are falling instead of rising, and gold is performing stronger. Ping An Securities believes that the current situation is still in a stalemate, and it is uncertain how far the "Trump trade" can go.
Merck Reports Results From Phase 2b/3 Clinical Trial Evaluating Clesrovimab; Results From MK-1654-004 Trial Met All Prespecified Endpoints
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
Smart Money Is Betting Big In UNH Options
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
Molina, Centene See Big Drops Following Elevance Health Profit Warning
Merck & Co Analyst Ratings
$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today